Danish biotech company granted millions to develop custom-made cancer vaccine
BY ALBERT RØNNING-ANDERSSON
Innovation Fund Denmark has granted a small Danish biotech company millions to develop a cancer vaccine targeting the unique cell changes in the individual patient. If the company succeeds, it will enter a billion-dollar market.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.